Sign in to view content

Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy The Phase II ALTITUDE Study

Dilsher S. Dhoot, MD

Video
Published 2023

Related

ZETA-1 Phase 2 Trial Efficacy Results for APX3330 a Novel Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy
David R Lally, MD
Annual Meeting Talks
2023
Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular
Daniel Su, MD
Updates from the Field
2018
Wide-Field Swept-Source Optical Coherence Tomography Angiography Versus Ultra-Wide Field Color Fundus Photo for Detecting Diabetic Retinopathy
Dan A Gong, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more